Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
30.6%
% of FTXH's 50 holdings also in XPH
36.6%
% of XPH's 41 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 7.2% | 4.2% | 4.2% |
|
ELI LILLY & CO | 3.9% | 4.0% | 3.9% |
|
JOHNSON & JOHNSON | 7.4% | 3.8% | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 7.1% | 3.7% | 3.7% |
|
ZOETIS INC | 3.6% | 4.7% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.4% |
|
MODERNA, INC. | 4.0% |
|
PFIZER INC | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.8% |
|
AMGEN INC | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.6% |
|
JOHNSON & JOHNSON | 3.6% |
|
GILEAD SCIENCES INC | 3.5% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% |
|
CARDINAL HEALTH INC | 3.4% |
FTXH Underweight Relative to XPH
|
REVANCE THERAPEUTICS INC | -6.0% |
|
CATALENT INC | -5.7% |
|
REATA PHARMACEUTICALS, INC. CLASS A | -5.5% |
 |
PERRIGO CO | -4.1% |
|
ROYALTY PHARMA PLC CLASS A | -3.6% |
|
AXSOME THERAPEUTICS, INC. | -3.2% |
|
INTRA-CELLULAR THERAPIES INC | -3.0% |
|
CASSAVA SCIENCES, INC. | -3.0% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.8% |
|
ELANCO ANIMAL HEALTH, INC. | -2.8% |